Value of antibiotic levels in serum and cardiac vegetations for predicting antibacterial effect of ceftriaxone in experimental Escherichia coli endocarditis
about
Biofilms: survival mechanisms of clinically relevant microorganisms.Efficacy of temafloxacin in experimental Streptococcus adjacens endocarditis and autoradiographic diffusion pattern of [14C]temafloxacin in cardiac vegetations.Opposite effects of cefoperazone and ceftazidime on S‑ribosylhomocysteine lyase/autoinducer-2 quorum sensing and biofilm formation by an Escherichia coli clinical isolate.Activity of sulbactam in combination with ceftriaxone in vitro and in experimental endocarditis caused by Escherichia coli producing SHV-2-like beta-lactamase.Ceftriaxone-sulbactam combination in rabbit endocarditis caused by a strain of Klebsiella pneumoniae producing extended-broad-spectrum TEM-3 beta-lactamase.Ceftriaxone-netilmicin combination in single-daily-dose treatment of experimental Escherichia coli endocarditis.Reduction in biliary excretion of ceftriaxone by diclofenac in rabbits.Pharmacokinetic and pharmacodynamic requirements for antibiotic therapy of experimental endocarditisSynergistic activity of ceftriaxone combined with netilmicin administered once daily for treatment of experimental streptococcal endocarditis.Simulated human serum profiles of one daily dose of ceftriaxone plus netilmicin in treatment of experimental streptococcal endocarditis.Parenteral sparfloxacin compared with ceftriaxone in treatment of experimental endocarditis due to penicillin-susceptible and -resistant streptococci.Bacterial biofilms: a diagnostic and therapeutic challenge.Single daily dosing of antibiotics: importance of in vitro killing rate, serum half-life, and protein bindingSignificance of tissue levels for prediction of antibiotic efficacy and determination of dosage.Combining Biofilm-Controlling Compounds and Antibiotics as a Promising New Way to Control Biofilm Infections.Guidelines for the antibiotic treatment of endocarditis in adults: report of the Working Party of the British Society for Antimicrobial Chemotherapy.
P2860
Q22299328-C6F3C772-4B15-4198-AE9B-69268D88C7A7Q30833424-4B078C08-9BDC-4887-9057-DA24867CBEECQ34426876-1CDAD717-983E-4CFD-96EC-7B0DCC127934Q35252077-6F201C67-1EAA-44DC-B3F3-60963745C58CQ35280038-C53022B7-DC68-463E-8DDB-4506DEB9DB9FQ35334285-F6FA3E91-156F-406B-BC69-48F5250D2E8DQ35348393-C587D598-3E98-484E-825C-D9B79A6334E0Q35534742-49CD9DA7-8174-4B11-8712-5935F5F8699EQ35808378-E6EC6871-06B2-4A0E-BF01-0C078FE978CAQ35819639-2436CB25-F71E-4B56-80C4-6EE0F28236C1Q35822840-CDA53F22-4932-42C2-A7D1-A879911766C5Q35917312-511432BB-B33F-4557-B1F2-B56C6DFEBC39Q36755849-D853FDE7-7325-4FD1-BDCE-CA78F6187EC0Q37977592-B605D4F3-C89D-407F-A423-FF3B7343BBFEQ38974289-74DC86E3-DE8F-4CDA-B6CE-A4EFB710DB0DQ53879693-9BB4E040-3A5F-43A0-99C0-5BD0601F395E
P2860
Value of antibiotic levels in serum and cardiac vegetations for predicting antibacterial effect of ceftriaxone in experimental Escherichia coli endocarditis
description
1987 nî lūn-bûn
@nan
1987 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1987 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
name
Value of antibiotic levels in ...... Escherichia coli endocarditis
@ast
Value of antibiotic levels in ...... Escherichia coli endocarditis
@en
type
label
Value of antibiotic levels in ...... Escherichia coli endocarditis
@ast
Value of antibiotic levels in ...... Escherichia coli endocarditis
@en
prefLabel
Value of antibiotic levels in ...... Escherichia coli endocarditis
@ast
Value of antibiotic levels in ...... Escherichia coli endocarditis
@en
P2093
P2860
P356
P1476
Value of antibiotic levels in ...... Escherichia coli endocarditis
@en
P2093
Contrepois A
Vallois JM
P2860
P304
P356
10.1128/AAC.31.10.1632
P407
P50
P577
1987-10-01T00:00:00Z